Cart
Orders
Not available hereProduct Overview
BBS Inj. is a fursultiamine hydrochloride injectable medicine from Huons Co., Ltd., classified by the manufacturer as a vitamin B1 medicinal preparation. The manufacturer declares fursultiamine hydrochloride 5.46 mg/mL and documents a 10 mL ampoule presentation. For professional product comparison, the specifications below distinguish manufacturer-listed packaging from the package assigned to this catalog listing, which has not been confirmed.
Key Features
- Declared active ingredient: Fursultiamine hydrochloride 5.46 mg/mL.
- Ampoule presentation: The manufacturer describes a clear liquid supplied in brown ampoules.
- Documented packaging: The manufacturer catalog lists 10 mL × 10 ampoules per box; the package for this listing is not verified.
Composition & Specifications
| Specification | Documented information |
|---|---|
| Manufacturer product name | BBS Inj. |
| Manufacturer | Huons Co., Ltd. |
| Product category | Vitamin B1 medicinal preparation; injectable medicine |
| Active ingredient | Fursultiamine hydrochloride 5.46 mg/mL |
| Declared ingredient equivalence | Equivalent to fursultiamine 5 mg/mL, as stated by the manufacturer; not a separate ingredient |
| Declared excipients | Water for injection, glucose |
| Presentation | Clear liquid in brown ampoules |
| Manufacturer-listed box | 10 mL × 10 ampoules |
| Package for this listing | Not publicly verified |
| Finished-product country of origin | Not verified |
Manufacturer-listed packaging describes a documented presentation, not a confirmed box quantity for this listing.
Product Label & Regulatory Notes
The South Korean Ministry of Food and Drug Safety product record identifies BBS injection under item identifier 200708473 and classifies it as a prescription medicine. The record displays an authorization date of July 23, 2007. Current authorization status has not been independently confirmed, and this record does not establish authorization in other jurisdictions.
Frequently Asked Questions
Why are two ingredient concentrations shown?
The manufacturer declares fursultiamine hydrochloride 5.46 mg/mL as equivalent to fursultiamine 5 mg/mL. These describe the declared salt and its stated fursultiamine equivalent, not two separate active ingredients.
Is the box quantity confirmed for this listing?
No. The manufacturer catalog documents a box of ten 10 mL ampoules, but the package corresponding to this catalog listing has not been verified.
Which supporting ingredients are declared?
The South Korean product record lists water for injection and glucose. Their quantities are not verified in the reviewed information.